{"name": "Corthera",
 "permalink": "corthera",
 "crunchbase_url": "http://www.crunchbase.com/company/corthera",
 "homepage_url": "http://www.corthera.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@corthera.com",
 "phone_number": "650-235-3555",
 "description": "Terminal Illness Medication",
 "created_at": "Tue Jul 14 05:05:00 UTC 2009",
 "updated_at": "Sat Aug 13 18:08:29 UTC 2011",
 "overview": "\u003Cp\u003ECorthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera\u00e2\u20ac\u2122s lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       41],
      "assets/images/resized/0005/2839/52839v1-max-150x150.jpg"],
     [[229,
       64],
      "assets/images/resized/0005/2839/52839v1-max-250x250.jpg"],
     [[229,
       64],
      "assets/images/resized/0005/2839/52839v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Executive Chairman",
    "person":
     {"first_name": "Dennis",
      "last_name": "Podlesak",
      "permalink": "dennis-podlesak",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5334/265334v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5334/265334v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5334/265334v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "CEO",
    "person":
     {"first_name": "Stan",
      "last_name": "Abel",
      "permalink": "stan-abel",
      "image": null}},
   {"is_past": true,
    "title": "Senior Director, Regulatory Affairs \u0026 Quality Assurance",
    "person":
     {"first_name": "Scott",
      "last_name": "Harris",
      "permalink": "scott-harris",
      "image": null}},
   {"is_past": true,
    "title": "Director, Operations",
    "person":
     {"first_name": "William",
      "last_name": "Martin",
      "permalink": "william-martin",
      "image": null}},
   {"is_past": true,
    "title": "Controller",
    "person":
     {"first_name": "Dina",
      "last_name": "Gonzalez",
      "permalink": "dina-gonzalez",
      "image": null}},
   {"is_past": true,
    "title": "Director, Business Development",
    "person":
     {"first_name": "Eric",
      "last_name": "Heil",
      "permalink": "eric-heil",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5376/265376v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5376/265376v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5376/265376v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$23M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.basmedical.com/investor20071220.html",
    "source_description": "Corthera Closes $23 Million Financing Round",
    "raised_amount": 23000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 12,
    "funded_day": 20,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Caxton Advantage Life Sciences Fund",
         "permalink": "caxton-advantage-life-sciences-fund",
         "image":
          {"available_sizes":
            [[[150,
               9],
              "assets/images/resized/0025/6631/256631v1-max-150x150.png"],
             [[250,
               15],
              "assets/images/resized/0025/6631/256631v1-max-250x250.png"],
             [[450,
               27],
              "assets/images/resized/0025/6631/256631v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kleiner Perkins Caufield \u0026 Byers",
         "permalink": "kleiner-perkins-caufield-byers",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 620000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.novartis.com/newsroom/media-releases/en/2009/1366823.shtml",
   "source_description": "Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III project relaxin for treatment of acute decompensated heart failure",
   "acquired_year": 2009,
   "acquired_month": 12,
   "acquired_day": 23,
   "acquiring_company":
    {"name": "Novartis",
     "permalink": "novartis",
     "image":
      {"available_sizes":
        [[[150,
           35],
          "assets/images/resized/0007/3011/73011v1-max-150x150.jpg"],
         [[163,
           39],
          "assets/images/resized/0007/3011/73011v1-max-250x250.jpg"],
         [[163,
           39],
          "assets/images/resized/0007/3011/73011v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "150 Industrial Road",
    "address2": "c/o Novartis",
    "zip_code": "94070",
    "city": "San Carlos",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.5594642,
    "longitude": -122.3024295}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        117],
       "assets/images/resized/0005/2840/52840v1-max-150x150.jpg"],
      [[250,
        195],
       "assets/images/resized/0005/2840/52840v1-max-250x250.jpg"],
      [[450,
        351],
       "assets/images/resized/0005/2840/52840v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}